Altered Regulatory B Cell Subsets in Children with Type 1 Diabetes Mellitus

Table 2

Correlations between B cell phenotypes and demographic, clinical and laboratory characteristics of the study patients.

Variable	B cell phenotype
	CD19^+ total B cells		IL10^+CD19^+ (IL10 B cells)		IL10^+CD24^hiCD27^+ (B10)		IL10^+CD24^hiCD38^hi (immature B cells)		IL10^+CD38^hiCD27^+ (plasmablast)
		value		value		value		value		value
Sex	-0.024	0.24	-0.018	0.40	-0.018	0.38	-0.014	0.87	0.017	0.35
Age	-0.043	0.09	-0.091	0.56	-0.370	0.09	-0.019	0.62	-0.084	0.45
Fasting blood glucose	-0.092	0.13	-0.041	0.08	-0.132	0.01	-0.124	0.01	-0.022	0.19
C-peptide	-0.013	0.80	-0.086	0.23	0.146	0.02	-0.01	0.42	-0. 017	0.26
HbA1c (%)	0.131	0.11	-0.168	0.02	-0.135	0.03	-0.1587	0.02	-0.056	0.41
ZnT8A	0.043	0.09	0.027	0.42	0.038	0.12	-0.025	0.91	0.038	0.23
GADA	0.092	0.13	0.017	0.28	0.01	0.78	0.017	0.44	0.024	0.54
IA2A	0.013	0.80	0.012	0.21	0.031	0.36	-0.045	0.06	0.054	0.23

indicate significance (P <0.05).